
Generation Bio Investor Relations Material
Latest events

Study Result
Generation Bio
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Generation Bio Co
Access all reports
Generation Bio Co. is a biotechnology company focused on the development of genetic medicines to treat both rare and prevalent diseases. Leveraging its proprietary platform, the company is working on a range of therapies aimed at addressing conditions affecting the liver, retina, skeletal muscle, central nervous system, and oncology. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the Nasdaq.
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
GBIO
Country
🇺🇸 United States